Nova Ltd. filed a Form 6-K with the U.S. Securities and Exchange Commission on November 5, 2026, disclosing record third-quarter 2026 financial results for the three-month period ended September 30, 2026.
HSBC Holdings plc filed a Form 6-K on November 5, 2026, announcing the anticipated launch of a cash tender offer to purchase up to $1,000,000,000 aggregate principal amount of its outstanding 6.000% Perpetual Subordinated Contingent Convertible Securities.
Polestar Automotive Holding UK PLC filed a Form 6-K on November 5, 2026, disclosing that its subsidiary Polestar Performance AB submitted a cross-border legal conversion plan to the Swedish Companies Registration Office, proposing to reincorporate as a Dutch B.V. under Dutch corporate law.
HSBC Holdings plc filed a Form 6-K on 5 November 2026, announcing the grant of conditional share awards to employees and former employees under the HSBC Share Plan 2011, with the grant dated 4 November 2026.
Twin Vee PowerCats Co. filed its Form 10-Q with the SEC on November 5, 2026, covering the quarterly period ended September 30, 2026, disclosing condensed consolidated financial results for its powercat boat manufacturing operations.
Director Siobhan Talbot of CRH Public Ltd Co filed a Form 4 on November 5, 2026, disclosing an open-market purchase of 2,000 ordinary shares on November 3, 2026.
Black Spade Acquisition III Co filed its Form 10-Q for the quarter ended September 30, 2026 with the SEC on November 5, 2026, reporting $177,073,722 held in its Trust Account and net income of $179,747 for the three-month period.
Graham Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting second-quarter and first-half financial results for fiscal year 2027.
Advanced Flower Capital Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 5, 2026, reporting a net increase in net assets from operations of $6,400,248 for the third quarter.
Envoy Medical, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter and nine-month period ended September 30, 2026, disclosing a net loss of $14,265 thousand for the nine months and $3,932 thousand for the …